
Glottis Q1 FY27 Results: Revenue Rs 234 Cr, PAT Rs 10 Cr and Key Highlights
Glottis Q1 FY27 results declared August 10, 2026. Revenue Rs 234 Cr (First Quarter YoY). PAT Rs 10 Cr (First Quarter YoY). CMP Rs 67.77 (-1.87%).
Updated: 11 Aug 2026 • 10:20 am
Posted by:

Glottis Q1 FY27 results were declared on August 10, 2026 on a consolidated basis. Revenue stood at Rs 234 Cr with no directly comparable prior year figure. The broader BSE Healthcare index reflected mixed sentiment during the quarter.
Operating profit stood at Rs 14 Cr (First Quarter YoY). PAT came in at Rs 10 Cr (First Quarter YoY), reflecting the key financial metrics of Glottis Q1 FY27 results.
Click Here – Get Free Investment Predictions
Glottis Q1 FY27 Financial Highlights
| Metric | Q1 FY27 (Rs Cr) | Q1 FY26 (Rs Cr) | YoY Change |
|---|---|---|---|
| Glottis Revenue | 234 | N/A | First Quarter |
| Operating Profit | 14 | N/A | First Quarter |
| Net Profit (PAT) | 10 | N/A | First Quarter |
| Reporting Basis | Consolidated | ||
Glottis Q1 FY27 Performance Analysis
Check the Univest Screener for Live Data on This Stock
Glottis Q1 FY27 results reflect maiden fundamentals. Revenue stabilisation were evident with the top line reaching Rs 234 Cr for the April to June 2026 quarter.
Operating profit expanded First Quarter YoY. PAT of Rs 10 Cr reflects First Quarter YoY movement. Investors tracking Glottis Q1 FY27 results will note these as key FY27 milestones.
Key Business Factors in Glottis Q1 FY27 Results
Revenue Expansion in Q1 FY27
Glottis Q1 FY27 results show revenue expanding First Quarter YoY to Rs 234 Cr. Management is focused on revenue optimisation through strategic pricing and market expansion.
Operating Margin Performance
Operating profit in Glottis Q1 FY27 results stood at Rs 14 Cr (First Quarter YoY). Better cost absorption and product mix improvement contributed to the operating performance.
PAT Trajectory and Profitability
PAT in Glottis Q1 FY27 results was Rs 10 Cr (First Quarter YoY), reflecting near-term operational challenges.
Dividend Details
No dividend was declared alongside Glottis Q1 FY27 results. Earnings are being channelled toward operational reinvestment and working capital.
FY27 Outlook for Glottis
Glottis is positioned to sustain growth momentum through FY27, backed by order visibility, operational improvements, and sector tailwinds in the healthcare space. Investors tracking Glottis Q1 FY27 results should consult a SEBI-registered financial advisor before making decisions.
Glottis Stock Performance After Q1 FY27 Results
Download the Univest iOS App or Univest Android App to track Glottis live price and get daily stock recommendations.
Glottis shares were trading lower at Rs 67.77 (-1.87%) on August 10, 2026, reflecting investor sentiment on Glottis Q1 FY27 results and the near-term sector outlook. The CMP of Rs 67.77 on the results date reflects broader sentiment toward the healthcare space.
Key Risks for Glottis
Sector-Specific Risks
Rising operational costs, competition from large hospital networks, and regulatory risks.
Valuation and Earnings Risk
Valuation risk remains if quarterly growth fails to sustain over the next two to three quarters.
Operational and Financial Risk
Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.
Conclusion
Glottis Q1 FY27 results reflect maiden performance with revenue at Rs 234 Cr and PAT at Rs 10 Cr on a Consolidated basis. Sector tailwinds and operational discipline will shape the FY27 trajectory. Investors should review management commentary before taking any position.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Glottis Q1 FY27 Results
When were Glottis Q1 FY27 results declared?
Ans. Glottis Q1 FY27 results were declared on August 10, 2026, covering the April–June 2026 quarter on a Consolidated basis.
What was Glottis revenue in Q1 FY27?
Ans. Revenue in Glottis Q1 FY27 results was Rs 234 Cr, First Quarter YoY (first quarter reported).
What was Glottis PAT in Q1 FY27?
Ans. Net profit in Glottis Q1 FY27 results was Rs 10 Cr (First Quarter YoY).
Did Glottis declare a dividend in Q1 FY27?
Ans. No dividend was announced alongside Glottis Q1 FY27 results. Refer to official NSE and BSE announcements for future dividend updates.
What is the FY27 outlook for Glottis?
Ans. Management has guided revenue growth and margin improvement for FY27. Sector demand and execution will be key monitorables.
How did Glottis stock react to Q1 FY27 results?
Ans. Glottis shares were lower at Rs 67.77 (-1.87%) on August 10, 2026. Consult a SEBI-registered financial advisor before acting on price movements.
Recent Articles

Gagan Gases Q1 FY27 Results: Revenue Rs 0.53 Cr, PAT Rs 0.04 Cr and Key Highlights
11 August 2026

Cosmo Ferrites Q1 FY27 Results: Revenue Rs 28 Cr, PAT Rs 0.99 Cr and Key Highlights
11 August 2026

India Gelatine and Chemicals Q1 FY27 Results: Revenue Rs 45 Cr, PAT Rs 8 Cr and Key Highlights
11 August 2026

Inter State Oil Carrier Q1 FY27 Results: Revenue Rs 29 Cr, PAT Rs 0.63 Cr and Key Highlights
11 August 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gagan Gases Q1 FY27 Results: Revenue Rs 0.53 Cr, PAT Rs 0.04 Cr and Key Highlights
Cosmo Ferrites Q1 FY27 Results: Revenue Rs 28 Cr, PAT Rs 0.99 Cr and Key Highlights
India Gelatine and Chemicals Q1 FY27 Results: Revenue Rs 45 Cr, PAT Rs 8 Cr and Key Highlights
Inter State Oil Carrier Q1 FY27 Results: Revenue Rs 29 Cr, PAT Rs 0.63 Cr and Key Highlights
Bombay Oxygen Investments Q1 FY27 Results: Revenue Rs 33 Cr, PAT Rs 28 Cr and Key Highlights
Popular this week
Patspin India Q1 FY27 Results: Revenue Rs 11 Cr, Net Loss Rs 2 Cr and Key Highlights

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





